A non-traditional crystal-based compound screening method targeting the ATP binding site of Plasmodium falciparum GRP78 for identification of novel nucleoside analogues

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Drug resistance to front-line malarial treatments represents an ongoing threat to control malaria, a vector borne infectious disease. The malarial parasite, Plasmodium falciparum has developed genetic variants, conferring resistance to the current standard therapeutic artemisinin and its derivatives commonly referred to as artemisinin-combination therapies (ACTs). Emergence of multi-drug resistance parasite genotypes is a warning of potential treatment failure, reaffirming the urgent and critical need to find and validate alternate drug targets to prevent the spread of disease. An attractive and novel drug target includes glucose-regulated protein 78 kDa (GRP78, or BiP), an essential molecular chaperone protein involved in the unfolded protein response that is upregulated in ACT treated P. falciparum parasites. We have shown that both sequence and structure are closely related to human GRP78 (hGRP78), a chaperone belonging to the HSP70 class of ATPase proteins, which is often upregulated in cellular stress responses and cancer. By screening a library of nucleoside analogues, we identified eight ‘hit’ compounds binding at the active site of the ATP binding domain of P. falciparum GRP78 using a high-throughput ligand soaking screen using x-ray crystallography. These compounds were further evaluated using protein thermal shift assays to assess target binding activity. The nucleoside analogues identified from our screen provide a starting point for the development of more potent and selective antimalarial inhibitors. In addition, we have established a well-defined, high-throughput crystal-based screening approach that can be applied to many crystallizable P. falciparum proteins for generating anti-Plasmodium specific compounds.

References Powered by Scopus

Coot: Model-building tools for molecular graphics

25804Citations
N/AReaders
Get full text

Overview of the CCP4 suite and current developments

10350Citations
N/AReaders
Get full text

REFMAC5 for the refinement of macromolecular crystal structures

6898Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy

6Citations
N/AReaders
Get full text

In silico identification of modulators of J domain protein-Hsp70 interactions in Plasmodium falciparum: a drug repurposing strategy against malaria

3Citations
N/AReaders
Get full text

Plasmodium falciparum heat shock proteins as antimalarial drug targets: An update

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mrozek, A., Antoshchenko, T., Chen, Y., Zepeda-Velázquez, C., Smil, D., Kumar, N., … Park, H. W. (2022). A non-traditional crystal-based compound screening method targeting the ATP binding site of Plasmodium falciparum GRP78 for identification of novel nucleoside analogues. Frontiers in Molecular Biosciences, 9. https://doi.org/10.3389/fmolb.2022.956095

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 2

50%

Lecturer / Post doc 1

25%

Researcher 1

25%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 2

50%

Medicine and Dentistry 1

25%

Business, Management and Accounting 1

25%

Save time finding and organizing research with Mendeley

Sign up for free